Company
Abbratech
We Target Human Diseases with Antibodies
Also known as Abbratech Inc.
- Business model
- B2B
- Headquarters
- Branford, Connecticut, United States
- Founded
- 2020
- Customers
- industry and academic partners
- Legal name
- Abbratech Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Antibody therapies are an increasingly important tool for treating diseases like cancer, immune disorders, and viral infections. The AbbraTech platform technology enables the discovery of antibodies against disease targets that are not accessible with conventional approaches.
Funding snapshot
- Latest round
- Round, $8.5M2023-11-27
Funding rounds
- Round, 2023
- $8.5M2023-11-27, SEC form D sold, 17 investors
Products
- Other
- Epivolve Technology
- Web
- Epivolve Technology
Loading relationship preview